Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hempolab is a Polish biotechnology company specializing in the extraction, purification, and analysis of cannabinoids from industrial hemp. Based in the Wrocław Technology Park, the company provides high-purity CBD and CBG isolates and distillates for the pharmaceutical, cosmetic, and nutraceutical industries. Hempolab operates a state-of-the-art laboratory equipped for supercritical CO2 extraction and advanced chromatography, offering both contract manufacturing and analytical testing services. Their focus is on delivering standardized, high-quality hemp-derived ingredients that meet rigorous safety and regulatory standards. The company also provides research and development services to help clients formulate new hemp-based products and optimize extraction processes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HEMPOLAB.